Obstet Gynecol Sci.  2015 Nov;58(6):475-480. 10.5468/ogs.2015.58.6.475.

Risk factors for malignant transformation of mature cystic teratoma

• Park CH
• Jung MH
• Ji YI

• KMID: 2314063
• DOI: http://doi.org/10.5468/ogs.2015.58.6.475

Abstract

OBJECTIVE
The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors.
METHODS
This was a retrospective study on 248 patients who were pathologically diagnosed with ovarian MCT, struma ovarii, or malignant transformations of these tumors at Inje University Haeundae Paik Hospital from March 2010 to January 2015. Routinely evaluated results of adnexal masses before surgery were compared.
RESULTS
A total of six patients (2.4%) were confirmed to have malignant tumors. Of the struma ovarii patients, two out of five patients (40%) were confirmed to have malignancy. The mean age at the diagnosis of patients with malignant transformation of teratomas was 43.0 years (range, 27 to 67 years), which was higher than that of patients with benign teratomas (36.5 years). The mean diameter of the tumor before surgery in the malignant tumor group was 11.4 cm and larger than 6.5 cm of benign group (P=0.003). The mean CA-125 level in the malignant tumor group was higher than that in the benign tumor group (P=0.01).
CONCLUSION
Risk factors for malignant transformation of MCT include elevated CA-125 levels, older age, large tumor masses, and postmenopausal status.

Keyword

Malignant transformation; Mature cystic teratoma; Struma ovarii

MeSH Terms

Diagnosis
Humans
Retrospective Studies
Risk Factors*
Struma Ovarii
Teratoma*

Reference

1. Disaia P, Creasman W. Germ cell stromal and other ovarian tumours. In : Disaia P, Creasman W, editors. Clinical gynaecological oncology. St Louis (MO): Mosby;1997. p. 351–371.

2. Sagae S, Kudo R. Surgery for germ cell tumors. Semin Surg Oncol. 2000; 19:76–81.

3. Curling OM, Potsides PN, Hudson CN. Malignant change in benign cystic teratoma of the ovary. Br J Obstet Gynaecol. 1979; 86:399–402.

4. Caspi B, Lerner-Geva L, Dahan M, Chetrit A, Modan B, Hagay Z, et al. A possible genetic factor in the pathogenesis of ovarian dermoid cysts. Gynecol Obstet Invest. 2003; 56:203–206.

5. Peterson WF. Malignant degeneration of benign cystic teratomas of the overy: a collective review of the literature. Obstet Gynecol Surv. 1957; 12:793–830.

6. Westhoff C, Pike M, Vessey M. Benign ovarian teratomas: a population-based case-control study. Br J Cancer. 1988; 58:93–98.

7. Singh P, Yordan EL, Wilbanks GD, Miller AW, Wee A. Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary. Singapore Med J. 1988; 29:30–34.

8. Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: clinicopathologic and topographic analysis. Am J Surg Pathol. 1989; 13:397–405.

9. Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H, Okamura H. Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Obstet Gynecol. 1991; 78(3 Pt 2):562–566.

10. Ueda Y, Kimura A, Kawahara E, Kitagawa H, Nakanishi I. Malignant melanoma arising in a dermoid cyst of the ovary. Cancer. 1991; 67:3141–3145.

11. Morimitsu Y, Nakashima O, Nakashima Y, Kojiro M, Shimokobe T. Apocrine adenocarcinoma arising in cystic teratoma of the ovary. Arch Pathol Lab Med. 1993; 117:647–649.

12. Rim SY, Kim SM, Choi HS. Malignant transformation of ovarian mature cystic teratoma. Int J Gynecol Cancer. 2006; 16:140–144.

13. Russel P, Farnsworth A. Teratomas with secondary malignant transformation. In : Russel P, Fansworth A, editors. Surgical pathology of the ovaries. 2nd ed. New York (NY): Churchill Livingston;1997. p. 545–551.

14. Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG. Struma ovarii: ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med. 1970; 72:883–893.

15. Wee JY, Li X, Chern BS, Chua IS. Struma ovarii: management and follow-up of a rare ovarian tumour. Singapore Med J. 2015; 56:35–39.

16. Gould SF, Lopez RL, Speers WC. Malignant struma ovarii: a case report and literature review. J Reprod Med. 1983; 28:415–419.

17. Telium G. Struma ovarii. In : Telium G, editor. Special tumors of ovary and testis. Philadelphia (PA): JB Lippincott;1971. p. 166.

18. Bhansali A, Jain V, Rajwanshi A, Lodha S, Dash RJ. Follicular carcinoma in a functioning struma ovarii. Postgrad Med J. 1999; 75:617–618.

19. Mlikotic A, McPhaul L, Hansen GC, Sinow RM. Significance of the solid component in predicting malignancy in ovarian cystic teratomas: diagnostic considerations. J Ultrasound Med. 2001; 20:859–866.

20. Kimura T, Inoue M, Miyake A, Tanizawa O, Oka Y, Amemiya K, et al. The use of serum TA-4 in monitoring patients with malignant transformation of ovarian mature cystic teratoma. Cancer. 1989; 64:480–483.

21. Kim SM, Choi HS, Byun JS, Kim YH, Kim KS, Rim SY, et al. Mucinous adenocarcinoma and strumal carcinoid tumor arising in one mature cystic teratoma of the ovary with synchronous cervical cancer. J Obstet Gynaecol Res. 2003; 29:28–32.

22. Tseng CJ, Chou HH, Huang KG, Chang TC, Liang CC, Lai CH, et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol. 1996; 63:364–370.

23. Nagata H, Takahashi K, Yamane Y, Yoshino K, Shibukawa T, Kitao M. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. Gynecol Obstet Invest. 1989; 28:165–168.

24. Dede M, Gungor S, Yenen MC, Alanbay I, Duru NK, Haşimi A. CA19-9 may have clinical significance in mature cystic teratomas of the ovary. Int J Gynecol Cancer. 2006; 16:189–193.

25. Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, et al. Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol. 2003; 90:338–341.

26. Kelley RR, Scully RE. Cancer developing in dermoid cysts of the ovary: a report of 8 cases, including a carcinoid and a leiomyosarcoma. Cancer. 1961; 14:989–1000.

27. Brammer HM 3rd, Buck JL, Hayes WS, Sheth S, Tavassoli FA. From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation. Radiographics. 1990; 10:715–724.

28. Zorlu CG, Kuscu E, Soysal ME, Caglar T, Aydogdu T, Cobanoglu O, et al. Malignant degeneration of mature cystic teratomas. Aust N Z J Obstet Gynaecol. 1996; 36:221–222.

29. Kikkawa F, Ishikawa H, Tamakoshi K, Nawa A, Suganuma N, Tomoda Y. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis. Obstet Gynecol. 1997; 89:1017–1022.

30. Ihalagama IR, Hewavisenthi SJ, Wijesinghe PS. Pregnancy following treated malignant struma ovarii. Ceylon Med J. 2004; 49:90–91.

31. Ayhan A, Tuncer ZS, Bilgin F, Kucukali T. Squamous cell carcinoma arising in dermoid cyst. Eur J Gynaecol Oncol. 1996; 17:144–147.

32. Stamp GW, McConnell EM. Malignancy arising in cystic ovarian teratomas: a report of 24 cases. Br J Obstet Gynaecol. 1983; 90:671–675.